Fluticasone propionate 50 μg BID versus 100 μg BID in the treatment of children with persistent asthma

丙酸氟替卡松 氟替卡松 医学 安慰剂 早晨 哮喘 皮质类固醇 内科学 麻醉 胃肠病学 病理 替代医学
作者
Yitzhak Katz,Francois X Lebas,Hilary Medley,Reid C. Robson
出处
期刊:Clinical Therapeutics [Elsevier BV]
卷期号:20 (3): 424-437 被引量:39
标识
DOI:10.1016/s0149-2918(98)80053-2
摘要

The aim of this multicenter, double-masked study was to compare the efficacy and safety of two different doses of inhaled fluticasone propionate dry powder--50 micrograms and 100 micrograms--administered BID via a multidose powder inhaler with those of placebo in the treatment of children with persistent asthma. After a 2-week run-in period, 263 patients were randomized to treatment with twice-daily placebo (n = 92), fluticasone 50 micrograms (n = 85), or fluticasone 100 micrograms (n = 86) for 12 weeks. One hundred sixty-six (63%) patients were male, and 224 (85%) were white, with a mean age of 8 years. Two hundred twenty-one (84%) patients were atopic, and 167 (63%) had been asthmatic for 1 to 5 years. Baseline mean morning peak expiratory flow (PEF) values were 207 L/min, 199 L/min, and 194 L/min, and baseline percentages of predicted normal values were 86%, 80%, and 81% for the groups receiving placebo, fluticasone 50 micrograms, and fluticasone 100 micrograms, respectively. At the end of the first week of treatment, patients in both fluticasone groups had significantly greater improvements in morning PEF than did those receiving placebo. Patients experienced mean increases of 4 L/min, 22 L/min, and 26 L/min with placebo, fluticasone 50 micrograms, and fluticasone 100 micrograms, respectively. At the end point (the last evaluable visit), patients in both fluticasone groups continued to have significantly greater improvements in morning PEF than did patients receiving placebo. Patients experienced mean increases of 17 L/min, 50 L/min, and 57 L/min with placebo, fluticasone 50 micrograms, and fluticasone 100 micrograms, respectively. Changes in the percentage of predicted values by end point were 8%, 20%, and 26% with placebo, fluticasone 50 micrograms, and fluticasone 100 micrograms, respectively. The probability of remaining in the study, according to predefined withdrawal criteria, indicated a significant treatment difference in favor of fluticasone. Withdrawal criteria were met by 63%, 42%, and 29% of patients receiving placebo, fluticasone 50 micrograms, and fluticasone 100 micrograms, respectively. This study clearly demonstrates the superiority of fluticasone 50 and 100 micrograms BID over placebo in the treatment of persistent asthma in children.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
wanci的应助被许娜采纳,获得10
1秒前
爆米花的应助被周小鱼采纳,获得10
1秒前
hhhhhh发布了新的文献求助10
1秒前
2秒前
凯歌发布了新的文献求助10
3秒前
3秒前
milai发布了新的文献求助10
3秒前
4秒前
FYhan发布了新的文献求助10
4秒前
4秒前
果粒橙子完成签到 ,获得积分10
4秒前
4秒前
领导范儿的应助被温文文采纳,获得10
5秒前
科研通AI6.2的应助被机智大船采纳,获得10
5秒前
董天完成签到,获得积分10
6秒前
白马非马jmh完成签到,获得积分10
6秒前
领导范儿的应助被一些小事采纳,获得10
6秒前
7秒前
7秒前
秋风的应助被孙禹采纳,获得20
7秒前
lhj完成签到,获得积分10
7秒前
evildoer发布了新的文献求助10
7秒前
8秒前
John的应助被番薯区丧彪采纳,获得10
8秒前
8秒前
肥肥完成签到 ,获得积分10
9秒前
灵运完成签到,获得积分10
9秒前
9秒前
小yang发布了新的文献求助10
10秒前
11秒前
肖肖发布了新的文献求助10
11秒前
今后的应助被damaozi采纳,获得10
11秒前
jx发布了新的文献求助10
11秒前
12秒前
12秒前
yanni完成签到,获得积分10
12秒前
12秒前
研友_VZG7GZ的应助被凯歌采纳,获得10
13秒前
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8163664
求助须知:如何正确求助?哪些是违规求助? 9557817
关于积分的说明 21741980
捐赠科研通 7754358
什么是DOI,文献DOI怎么找? 3428338
关于科研通互助平台的介绍 2553000
邀请新用户注册赠送积分活动 2472943